Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.94
Delayed Data
As of Oct 18
 +0.13 / +7.18%
Today’s Change
0.74
Today|||52-Week Range
2.17
+44.78%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.81
Today’s open1.85
Day’s range1.79 - 1.95
Volume693,883
Average volume (3 months)563,875
Market cap$266.1M
Dividend yield--
Data as of 10/18/2017

Growth & Valuation

Earnings growth (last year)-36.84%
Earnings growth (this year)+19.23%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-26.66%
P/E ratioNM
Price/Sales12.72
Price/Book30.67

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...-0.55-6.79%
CPRXCatalyst Pharmaceuti...+0.01+0.40%
OVIDOvid Therapeutics In...-0.49-5.62%
ABUSArbutus Biopharma Co...-0.30-4.32%
Data as of 10/18/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$14.0M
Annual profit (last year)-$34.5M
Net profit margin-246.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts